Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 13 May 2026 for Arcutis Biotherapeutics, Inc., €7,773. Read the official filing
Filing timeline
BuySaleLatha Vairavan
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Latha Vairavan: trading record in brief
Latha Vairavan is a declared insider of Arcutis Biotherapeutics, Inc. (finance chief), with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 6 May 2025 and the latest from 11 May 2026.
No open-market purchase appears, only 5 sales worth €66k. Besides market trades, the filings include 2 share grants. In 2026 alone, the filings show no purchases and 3 sales.
On 13 May 2026 came the latest disclosure, an open-market sale for €7,773 in Arcutis Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Latha Vairavan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
435 shares@ US$21.050.0003% mcap11.7% of flowCommon StockSEC:0002065881-26-000004:0
1,341 shares@ US$23.61060.0010% mcap40.9% of flowCommon StockSEC:0002065881-26-000002:0
27,000 shares0Common StockSEC:0001628280-26-014325:0
1,320 shares@ US$25.498442.9% of flowCommon StockSEC:0001628280-26-005568:0
88 shares@ US$24.71852.8% of flowCommon StockSEC:0002065881-25-000035:0
89 shares@ US$14.32661.7% of flowCommon StockSEC:0001787306-25-000117:0
20,000 shares0Common StockSEC:0002065881-25-000005:0
7 of 7 declarations
